Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Response: relationship between vitamin D and depression in multiple sclerosis.
The relationship between upper leg muscle strength and walking capacity in persons with multiple sclerosis.
Frequency of circulating autoreactive T cells committed to myelin determinants in relapsing-remitting multiple sclerosis patients.
MHC-mismatched mixed chimerism augments thymic regulatory T-cell production and prevents relapse of EAE in mice.
Brain MRI of nasal MOG therapeutic effect in relapsing-progressive EAE.
MRI measures should be a primary outcome endpoint in phase III randomised controlled trials in multiple sclerosis: Commentary.
Use of Complementary and Alternative Medicine among People with Multiple Sclerosis in the Nordic Countries.
Tumefactive demyelination: an approach to diagnosis and management.
Gateway to wellness: an occupational therapy collaboration with the national multiple sclerosis society.
Signaling and Regulatory Functions of Bioactive Sphingolipids as Therapeutic Targets in Multiple Sclerosis.
Soluble helminth products suppress clinical signs in murine experimental autoimmune encephalomyelitis and differentially modulate human dendritic cell activation.
Rhythmic auditory cueing to improve walking in patients with neurological conditions other than Parkinson's disease - what is the evidence?
Association of Viruses in Neurodegenerative and Neurobehavioral Diseases.
The effects of robot-assisted gait training in progressive multiple sclerosis: A randomized controlled trial.
Extracting quantitative measures from EAP: a small clinical study using BFOR.
The behavior-analytic origins of constraint-induced movement therapy: an example of behavioral neurorehabilitation.
Casting light on multiple sclerosis heterogeneity: the role of HLA-DRB1 on spinal cord pathology.
Hope for a rare disease: eculizumab in neuromyelitis optica.
Stress, Depression and Antidepressant Treatment Options in Patients Suffering from Multiple Sclerosis.
The effect of intravenous immunoglobulin on neuromyelitis optica.
[Treatment of nausea and vomiting with 5HT3 receptor antagonists, steroids, antihistamines, anticholinergics, somatostatinantagonists, benzodiazepines and cannabinoids in palliative care patients : A systematic review.]
Nanoparticle-mediated codelivery of myelin antigen and a tolerogenic small molecule suppresses experimental autoimmune encephalomyelitis.
Reproductive decision making after the diagnosis of multiple sclerosis (MS).
Gemfibrozil, a lipid-lowering drug, increases myelin genes in human oligodendrocytes via peroxisome proliferator-activated receptor beta.
Setting new standards in multiple sclerosis care and research.
Pages
« first
‹ previous
…
197
198
199
200
201
202
203
204
205
…
next ›
last »